TORONTO, Oct. 4, 2021 /CNW/ - Khiron Life Sciences Corp.
("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)
(Frankfurt: A2JMZC), a vertically
integrated cannabis leader with core operations in Latin America and Europe, is scheduled to participate in the
following virtual investor conferences in October 2021:
A.G.P.' S VIRTUAL FALL CONSUMER CANNABIS
CONFERENCE
Attending 1x1 Meetings: Tuesday, October 5th 2021
Moderator: Aaron Grey, Managing
Director, Equity Research Consumer & Cannabis
LYTHAM PARTNERS FALL 2021 INVESTOR CONFERENCE
Khiron
Presentation: Thursday, October
7th at 9:30 p.m.
ET
Webcast: https://www.webcaster4.com/Webcast/Page/2783/42914
Panel "Growing without Borders, an International
Perspective":
Thursday, October 7th at
11:30 p.m. ET
Webcast:
https://www.meetmax.com/sched/event_75709/conference_register.html?bank_access=0&event_id=75709&attendee_role_id=INVESTOR
MJBIZ CONFERENCE
Thursday,
October 15th at 4:00 p.m ET
Panel Participation: The Latin American Cannabis Supply Chain:
Do's, Don'ts and Industry Domination
BENZINGA CANNABIS CAPITAL CONFERENCE
Marriott Marquis
Hotel in New York City
- Khiron Presentation: Friday, October
15th at 3:45 p.m ET
- Virtual executive interview with Mr. Vicente Fox: Thursday,
October 14th & 15th at 1:10 p.m
ET
- Panel: International Spotlight - Continued Cannabis Expansion
in European Markets: Friday, October
15th at 2:10 p.m ET
A.G.P's hosted events are intended for prospective and existing
A.G.P's clients only. To listen to the live event, please contact
you're A.G.P's representative with interest.
For more information about the Lytham Partners Conference or to
schedule a 1-on-1 meeting with Khiron, please contact a Lytham
Partners representative at 1x1@lythampartners.com or register
at www.lythampartners.com/fall2021invreg
Interested parties for the Benzinga Cannabis Capital Conference
can register to attend here.
Members of the Khiron management will also be holding one-on-one
investor meetings throughout the day. For more information about
the conference or to schedule a 1-on-1 meeting with Khiron
management, please call the company's investor relations team at
1-647-556-5750
Interested parties for the MJBizCon can register to
attend here.
About Khiron Life Sciences Corp.
Khiron is a leading
vertically integrated international medical cannabis company with
core operations in Latin America
and Europe. Leveraging
wholly-owned medical health clinics and proprietary telemedicine
platforms, Khiron combines a patient-oriented approach, physician
education programs, scientific expertise, product innovation, and
agricultural infrastructure to drive prescriptions and brand
loyalty with patients worldwide. The Company has a sales presence
in Colombia, Peru, Germany, UK, and Brazil and is positioned to commence sales in
Mexico. The Company is led by
Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and
diverse executive team and Board of Directors.
Visit Khiron online at investors.khiron.ca
Linkedin
https://www.linkedin.com/company/khiron-life-sciences-corp/
Cautionary Notes
Forward-Looking Statements
This press release may contain certain "forward-looking
information" and "forward-looking statements" within the meaning of
applicable securities legislation. All information contained herein
that is not historical in nature may constitute forward-looking
information. Khiron undertakes no obligation to comment on
analyses, expectations or statements made by third-parties in
respect of Khiron, its securities, or financial or operating
results (as applicable). Although Khiron believes that the
expectations reflected in forward-looking statements in this press
release are reasonable, such forward-looking statement has been
based on expectations, factors and assumptions concerning future
events which may prove to be inaccurate and are subject to numerous
risks and uncertainties, certain of which are beyond Khiron's
control, including the risk factors discussed in Khiron's Annual
Information Form which is available on Khiron's SEDAR profile at
www.sedar.com. The forward-looking information contained in this
press release is expressly qualified by this cautionary statement
and is made as of the date hereof. Khiron disclaims any intention
and has no obligation or responsibility, except as required by law,
to update or revise any forward-looking information, whether as a
result of new information, future events or otherwise.
Neither the TSXV nor its Regulation Services Provider (as that
term is defined in the policies of the TSXV) accepts responsibility
for the adequacy or accuracy of this press release.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/khiron-life-sciences-to-present-at-upcoming-october-investor-conferences-301392199.html
SOURCE Khiron Life Sciences Corp.